Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Biswas, Rupa ^a   Bunderson Schelvan, Melisa ^a   Holian, Andrij ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; ANTITUSSIVE AGENT; ASBESTOS; BOSENTAN; BRONCHODILATING AGENT; CATHEPSIN B; CORTICOSTEROID; CYTOKINE; CYTOTOXIC AGENT; ETANERCEPT; GAMMA INTERFERON; IMATINIB; IMMUNOSUPPRESSIVE AGENT; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NANOMATERIAL; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADAPTIVE IMMUNITY; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG ACTIVITY; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG FIBROSIS; LUNG TRANSPLANTATION; LYSOSOME MEMBRANE; NONHUMAN; OXYGEN THERAPY; PATIENT ATTITUDE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84857845432     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/105707     Document Type: Review

References (78)

1. Pulmonary Fibrosis Foundation, 2010, http://www.pulmonaryfibrosis.org
2. Olson A. L., Swigris J. J., Lezotte D. C., Norris J. M., Wilson C. G., Brown K. K., Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003 American Journal of Respiratory and Critical Care Medicine 2007 176 3 277 284 (Pubitemid 47195878)
3. Vaillant P., The role of cytokines in human lung fibrosis Monaldi Archives for Chest Disease 1996 51 2 145 152 (Pubitemid 26179318)
4. Pardo A., Selman M., Kaminski N., Approaching the degradome in idiopathic pulmonary fibrosis International Journal of Biochemistry and Cell Biology 2008 40 6-7 1141 1155
5. Gogali A., Wells A. U., New pharmacological strategies for the treatment of pulmonary fibrosis Therapeutic Advances in Respiratory Disease 2010 4 6 353 366
6. Sime P. J., Xing Z., Graham F. L., Csaky K. G., Gauldie J., Adenovector-mediated gene transfer of active transforming growth factor- 1 induces prolonged severe fibrosis in rat lung The Journal of Clinical Investigation 1997 100 4 768 776 (Pubitemid 27371693)
7. Desai B., Mattson J., Paintal H., Nathan M., Shen F., Beaumont M., Malinao M.-C., Li Y., Canfield J., Basham B., De Waal Malefyt R., McClanahan T., Krishna G., Fick Jr. R., Differential expression of monocyte/macrophage- selective markers in human idiopathic pulmonary fibrosis Experimental Lung Research 2011 37 4 227 238
8. Bournazos S., Grinfeld J., Alexander K. M., Murchison J. T., Wallace W. A., McFarlane P., Hirani N., Simpson A. J., Dransfield I., Hart S. P., Association of Fc RIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression BMC Pulmonary Medicine 2010 10 51 57
9. Wuyts W. A., Willems S., Vos R., Vanaudenaerde B. M., De Vleeschauwer S. I., Rinaldi M., Vanhooren H. M., Geudens N., Verleden S. E., Demedts M. G., Thomeer M., Verbeken E. K., Verleden G. M., Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model Experimental Lung Research 2010 36 10 602 614
10. Kottmann R. M., Hogan C. M., Phipps R. P., Sime P. J., Determinants of initiation and progression of idiopathic pulmonary fibrosis Respirology 2009 14 7 917 933
11. Geiser M., Update on macrophage clearance of inhaled micro- and nanoparticles Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010 23 4 207 217
12. Sakai M., Araki N., Ogawa K., Lysosomal movements during heterophagy and autophagy: with special reference to nematolysosome and wrapping lysosome Journal of Electron Microscopy Technique 1989 12 2 101 131
13. Bowden D. H., The alveolar macrophage Environmental Health Perspectives 1984 55 327 341 (Pubitemid 14094818)
14. Johansson A. C., Appelqvist H., Nilsson C., Kgedal K., Roberg K., llinger K., Regulation of apoptosis-associated lysosomal membrane permeabilization Apoptosis 2010 15 5 527 540
15. Beamer C. A., Migliaccio C. T., Jessop F., Trapkus M., Yuan D., Holian A., Innate immune processes are sufficient for driving silicosis in mice Journal of Leukocyte Biology 2010 88 3 547 557
16. Morishige T., Yoshioka Y., Inakura H., Tanabe A., Yao X., Narimatsu S., Monobe Y., Imazawa T., Tsunoda S. I., Tsutsumi Y., Mukai Y., Okada N., Nakagawa S., The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1 production, ROS production and endosomal rupture Biomaterials 2010 31 26 6833 6842
17. Hamilton R. F. Jr., Thakur S. A., Holian A., Silica binding and toxicity in alveolar macrophages Free Radical Biology and Medicine 2008 44 7 1246 1258
18. Jin C., Flavell R. A., Molecular mechanism of NLRP3 inflammasome activation Journal of Clinical Immunology 2010 30 5 628 631
19. Thomeer M. J., Costabel U., Rizzato G., Poletti V., Demedts M., Comparison of registries of interstitial lung diseases in three European countries European Respiratory Journal, Supplement 2001 18 32 114s 118s (Pubitemid 34755192)
20. Camus P., Fanton A., Bonniaud P., Camus C., Foucher P., Interstitial lung disease induced by drugs and radiation Respiration 2004 71 4 301 326 (Pubitemid 39179164)
21. van der Veen M. J., Dekker J. J., Dinant H. J., van Soesbergen R. M., Bijlsma J. W. J., Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis Journal of Rheumatology 1995 22 9 1766 1768
22. Suwa A., Hirakata M., Satoh S., Mimori T., Utsumi K., Inada S., Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy Clinical and Experimental Rheumatology 1999 17 3 355 358 (Pubitemid 29265686)
23. Scriabine A., Rabin D. U., New developments in the therapy of pulmonary fibrosis Advances in Pharmacology 2009 57 419 464
24. Gasse P., Riteau N., Charron S., Girre S., Fick L., Pétrilli V., Tschopp J., Lagente V., Quesniaux V. F. J., Ryffel B., Couillin I., Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis American Journal of Respiratory and Critical Care Medicine 2009 179 10 903 913
25. Gasse P., Mary C., Guenon I., Noulin N., Charron S., Schnyder-Candrian S., Schnyder B., Akira S., Quesniaux V. F. J., Lagente V., Ryffel B., Couillin I., IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice The Journal of Clinical Investigation 2007 117 12 3786 3799 (Pubitemid 350224089)
26. Imaeda A. B., Watanabe A., Sohail M. A., Mahmood S., Mohamadnejad M., Sutterwala F. S., Flavell R. A., Mehal W. Z., Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome The Journal of Clinical Investigation 2009 119 2 305 314
27. Chan E. S. L., Cronstein B. N., Adenosine in fibrosis Modern Rheumatology 2010 20 2 114 122
28. McDonald B., Pittman K., Menezes G. B., Hirota S. A., Slaba I., Waterhouse C. C. M., Beck P. L., Muruve D. A., Kubes P., Intravascular danger signals guide neutrophils to sites of sterile inflammation Science 2010 330 6002 362 366
29. Wilson M. S., Wynn T. A., Pulmonary fibrosis: pathogenesis, etiology and regulation Mucosal Immunology 2009 2 2 103 121
30. Mayo Clinic: Education and Research, 2010, http://www.mayo.edu
31. King T.E. Jr., Costabel U., Cordier J.-F., DoPico G. A., DuBois R. M., Lynch D., Lynch J. P. III, Myers J., Panos R., Raghu G., Schwartz D., Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement American Journal of Respiratory and Critical Care Medicine 2000 161 2, part 1 646 664 (Pubitemid 30129480)
32. Wang Z. L., Advances in understanding of idiopathic pulmonary fibrosis Chinese Medical Journal 2009 122 7 844 857
33. Tripathi K. D., Essentials of Medical Pharmacology 2004 5th New Delhi, India Jaypee Brothers Medical Publishers
34. Hunninghake G. W., Kalica A. R., Approaches to the treatment of pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 1995 151 3, part 1 915 918
35. Wells S. M., Buford M. C., Migliaccio C. T., Holian A., Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice American Journal of Respiratory Cell and Molecular Biology 2009 40 2 179 188
36. Piguet P. F., Vesin C., Grau G. E., Thompson R. C., Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica Cytokine 1993 5 1 57 61 (Pubitemid 23098835)
37. Dinarello C. A., Interleukin-1, interleukin-18, and the interleukin-1 converting enzyme Annals of the New York Academy of Sciences 1998 856 1 11
38. Soo J. C., Min J. K., Homer R. J., Hye R. K., Zhang X., Lee P. J., Elias J. A., Chun G. L., Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling The Journal of Biological Chemistry 2006 281 12 8161 8168 (Pubitemid 43847435)
39. Zheng T., Liu W., Oh S. Y., Zhu Z., Hu B., Homer R. J., Cohn L., Grusby M. J., Elias J. A., IL-13 receptor 2 selectively inhibits IL-13-induced responses in the murine lung Journal of Immunology 2008 180 1 522 529
40. Belperio J. A., Dy M., Burdick M. D., Xue Y. Y., Li K., Elias J. A., Keane M. P., Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis American Journal of Respiratory Cell and Molecular Biology 2002 27 4 419 427
41. Selman M., Carrillo G., Estrada A., Mejia M., Becerril C., Cisneros J., Gaxiola M., Pérez-Padilla R., Navarro C., Richards T., Dauber J., King T. E., Pardo A., Kaminski N., Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern PLoS One 2007 2 5, article e482
42. Allam J. S., Limper A. H., Idiopathic pulmonary fibrosis: is it a familial disease? Current Opinion in Pulmonary Medicine 2006 12 5 312 317 (Pubitemid 44315774)
43. Lee H. L., Ryu J. H., Wittmer M. H., Hartman T. E., Lymp J. F., Tazelaar H. D., Limper A. H., Familial idiopathic pulmonary fibrosis: clinical features and outcome Chest 2005 127 6 2034 2041
44. Dinarello C. A., IL-18: at-inducing, proinflammatory cytokine and new member of the IL-1 family Journal of Allergy and Clinical Immunology 1999 103 1, part 1 11 24 (Pubitemid 29063184)
45. Drenth J. P. H., van der Meer J. W. M., The inflammasomea linebacker of innate defense The New England Journal of Medicine 2006 355 7 730 732
46. Hoffman H. M., Wanderer A. A., Inflammasome and IL-1 -mediated disorders Current Allergy and Asthma Reports 2010 10 4 229 235
47. Proell M., Riedl S. J., Fritz J. H., Rojas A. M., Schwarzenbacher R., The Nod-Like Receptor (NLR) family: a tale of similarities and differences PLoS One 2008 3 4
48. Pedra J. H., Cassel S. L., Sutterwala F. S., Sensing pathogens and danger signals by the inflammasome Current Opinion in Immunology 2009 21 1 10 16
49. Franchi L., Eigenbrod T., Muoz-Planillo R., Nuez G., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Nature Immunology 2009 10 3 241 247
50. Dinarello C. A., Immunological and inflammatory functions of the interleukin-1 family Annual Review of Immunology 2009 27 519 550
51. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J., Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 2006 440 7081 237 241 (Pubitemid 43372104)
52. Hornung V., Bauernfeind F., Halle A., Samstad E. O., Kono H., Rock K. L., Fitzgerald K. A., Latz E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization Nature Immunology 2008 9 8 847 856
53. Boya P., Kroemer G., Lysosomal membrane permeabilization in cell death Oncogene 2008 27 50 6434 6451
54. Guicciardi M. E., Leist M., Gores G. J., Lysosomes in cell death Oncogene 2004 23 16 2881 2890 (Pubitemid 38638850)
55. Faustin B., Lartigue L., Bruey J. M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J. C., Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation Molecular Cell 2007 25 5 713 724 (Pubitemid 46341921)
56. Dostert C., Pétrilli V., van Bruggen R., Steele C., Mossman B. T., Tschopp J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 2008 320 5876 674 677 (Pubitemid 351928351)
57. Cassel S. L., Eisenbarth S. C., Iyer S. S., Sadler J. J., Colegio O. R., Tephly L. A., Carter A. B., Rothman P. B., Flavell R. A., Sutterwala F. S., The Nalp3 inflammasome is essential for the development of silicosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 26 9035 9040
58. Hentze H., Lin X. Y., Choi M. S. K., Porter A. G., Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin Cell Death and Differentiation 2003 10 9 956 968 (Pubitemid 37069473)
59. Gieling R. G., Wallace K., Han Y. P., Interleukin-1 participates in the progression from liver injury to fibrosis American Journal of Physiology 2009 296 6 G1324 G1331
60. Zuo F., Kaminski N., Eugui E., Allard J., Yakhini Z., Ben-Dor A., Lollini L., Morris D., Kim Y., DeLustro B., Sheppard D., Pardo A., Selman M., Heller R. A., Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans Proceedings of the National Academy of Sciences of the United States of America 2002 99 9 6292 6297 (Pubitemid 34493305)
61. Bani-Hani A. H., Leslie J. A., Asanuma H., Dinarello C. A., Campbell M. T., Meldrum D. R., Zhang H., Hile K., Meldrum K. K., IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis Kidney International 2009 76 5 500 511
62. Hu Y., Liang D., Li X., Liu H.-H., Zhang X., Zheng M., Dill D., Shi X., Qiao Y., Yeomans D., Carvalho B., Angst M. S., Clark J. D., Peltz G., The role of interleukin-1 in wound biology. part II: in vivo and human translational studies Anesthesia and Analgesia 2010 111 6 1534 1542
63. Agostini C., Gurrieri C., Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis Proceedings of the American Thoracic Society 2006 3 4 357 363 (Pubitemid 43845413)
64. Phan S. H., The myofibroblast in pulmonary fibrosis Chest 2002 122 6, supplement 286S 289S (Pubitemid 36043014)
65. Dinarello C. A., Biologic basis for interleukin-1 in disease Blood 1996 87 6 2095 2147 (Pubitemid 26086851)
66. Alboni S., Cervia D., Sugama S., Conti B., Interleukin 18 in the CNS Journal of Neuroinflammation 2010 7, article 9
67. Liu X., Inflammatory cytokines augments TGF- 1-induced epithelial-mesenchymal transition in A549 cells by up-regulating T R-I Cell Motility and the Cytoskeleton 2008 65 12 935 944
68. Chaudhuri V., Zhou L., Karasek M., Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis Journal of Cutaneous Pathology 2007 34 2 146 153 (Pubitemid 46145554)
69. Vidal B., Serrano A. L., Tjwa M., Suelves M., Ardite E., De Mori R., Baeza-Raja B., De Lagrn M. M., Lafuste P., Ruiz-Bonilla V., Jard M., Gherardi R., Christov C., Dierssen M., Carmeliet P., Degen J. L., Dewerchin M., Muoz-Cnoves P., Fibrinogen drives dystrophic muscle fibrosis via a TGF /alternative macrophage activation pathway Genes and Development 2008 22 13 1747 1752 (Pubitemid 351915499)
70. Davis M. J., Swanson J. A., Technical advance: caspase-1 activation and IL-1 release correlate with the degree of lysosome damage, as illustrated by a novel imaging method to quantify phagolysosome damage Journal of Leukocyte Biology 2010 88 4 813 822
71. Nel A., Xia T., Mdler L., Li N., Toxic potential of materials at the nanolevel Science 2006 311 5761 622 627 (Pubitemid 43191298)
72. Hamilton R. F., Wu N., Porter D., Buford M., Wolfarth M., Holian A., Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity Particle and Fibre Toxicology 2009 6, article 35
73. Datta A., Scotton C. J., Chambers R. C., Novel therapeutic approaches for pulmonary fibrosis British Journal of Pharmacology 2011 163 1 141 172
74. Spagnolo P., Del Giovane C., Luppi F., Cerri S., Balduzzi S., Walters E. H., D'Amico R., Richeldi L., Non-steroid agents for idiopathic pulmonary fibrosis Cochrane database of systematic reviews (Online) 2010 9
75. Hawkins P. N., Lachmann H. J., McDermott M. F., Interleukin-1-receptor antagonist in the Muckle-Wells syndrome The New England Journal of Medicine 2003 348 25 2583 2584
76. Molt A., Olivé A., Anti-IL-1 molecules: new comers and new indications Joint Bone Spine 2010 77 2 102 107
77. Liu N., Raja S. M., Zazzeroni F., Metkar S. S., Shah R., Zhang M., Wang Y., Brmme D., Russin W. A., Lee J. C., Peter M. E., Froelich C. J., Franzoso G., Ashton-Rickardt P. G., NF- B protects from the lysosomal pathway of cell death The EMBO Journal 2003 22 19 5313 5322 (Pubitemid 37222050)
78. Liu N., Wang Y., Ashton-Rickardt P. G., Serine protease inhibitor 2A inhibits caspase-independent cell death The FEBS Letters 2004 569 13 49 53 (Pubitemid 38844591)